Bluefin Capital Management, LLC Takeda Pharmaceutical CO LTD Transaction History

Bluefin Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$13.17 - $16.4 $167,575 - $208,673	-12,724 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$16.3 - $17.26 $207,401 - $219,616	12,724 New	12,724 $208,000
Q2 2021 Aug 16, 2021	SELL	$16.55 - $18.64 $570,792 - $642,874	-34,489 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.71 - $19.9 $576,311 - $686,331	34,489 New	34,489 $630,000

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bluefin Capital Management, LLC with notifications on news.